Tretinoin Clinical Trials

1 actively recruiting trial across 1 location

Also known as: 2,4,6,8-Nonatetraenoic acid, 3, 7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-E)-, ATRA, Aberel, Airol, Aknoten, All-trans Retinoic Acid, All-trans Vitamin A Acid, Avita, Cordes Vas, Dermairol, Epi-Aberel, Eudyna, Renova, Retin-A, Retin-A MICRO, Retin-A-Micro, Retisol-A, Ro 5488, Stieva-A, Stieva-A Forte, Trans Retinoic Acid, Trans Vitamin A Acid, Tretinoinum, Vesanoid, Vitamin A acid, all-trans-, Vitinoin, all trans-Retinoic acid, all-trans-Retinoic acid, all-trans-Vitamin A acid, beta-Retinoic Acid, retinoic acid, trans-Retinoic acid, vitamin A acid

Filter by location:

Houston, Texas1 trial

Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

M D Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.